PERSPECTIVE
Siemens Healthineers said on November 5 that it had begun carving out its in vitro diagnostics business. The business will take the name Olyrian Diagnostics in stages. Siemens Healthineers expects the transition to be completed by mid-2028 and says the unit will remain part of the group during that period.
The unit spans laboratory automation, informatics and point-of-care testing. For labs that depend on these systems, service, reagent supply and software support can matter as much as the instruments themselves. Suppliers and partners will also need to know who is responsible for joint development and distribution as the business moves toward operating independently.
Siemens Healthineers says products, services, contracts and customer contacts are unchanged at the announcement. The mid-2028 date is a target for the transition. The updates that matter next are the ones that tell customers who will support their installed systems and on what terms.
ORIGINAL SOURCES